Charles Conroy, RPh, MBA
Chief Executive Officer at Nucleus Radiopharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Nucleus RadioPharma
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Executive Officer
-
Sep 2022 - 1 year 4 months
Charlotte, North Carolina, United States Transforming lives with radiopharmaceuticals by leveraging world class clinical, development, manufacturing, and supply chain expertise. Nucleus bridges the gap between innovation and clinic.
-
-
-
ARTMS Inc
-
Canada
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Chief Executive Officer
-
Sep 2019 - Oct 2022
Created the culture and build the teams that was responsible for realizing the full commercial potential of the company’s technologies. Additionally, I held responsibility for establishing strategic direction and led in the development of partnerships and alliances to create new markets, grow revenues and optimize shareholder value.
-
-
-
Jubilant Pharma Limited
-
United States
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
General Manager
-
2018 - Sep 2019
Directed all activities, including operations and sales, for $200 million specialty division with over 800 employees across 51 locations. Drove the company to achieve and surpass sales, profitability, cash flow and business goals and objectives. Spearheaded the development, communication and implementation of effective growth strategies and processes.
-
-
-
-
Chief Operating Officer | COO
-
2016 - 2018
Oversaw all operations and managed key supply chain relationships for private equity backed, nationwide specialty pharmacy business focusing on the federal 340B drug program, retroviruses, mental and behavioral health, custom compounding, and pain management. Acted as lead “client-care officer” through direct contact with clients and business partners.
-
-
-
Express Scripts
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Senior Director, Pharmacy Operations
-
2013 - 2016
Oversaw all aspects of the 500-employee fulfillment operation within Express Scripts' flagship pharmacy. Located in the Technology and Innovation Center, the pharmacy utilizes cutting edge processes and technology to fill over 100,000 prescriptions daily and serve tens of millions of patients annually.
-
-
Director of Pharmacy Practice
-
2013 - 2016
Oversaw the practice of pharmacy at the corporation’s Technology and Innovation Center, which employs more than 500 professional, technical and clerical staff fulfilling in excess of 100,000 prescriptions daily.
-
-
-
UBC
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Director, Pharma Client Services
-
2013 - 2016
Operational and Program Management leader responsible for large (>$1B annual revenues), multi-site national programs (AbbVie, Allergan, Amgen, AstraZeneca, Gilead, Johnson & Johnson, Pfizer, plus 65 others) supported by pharmacists, pharmacy technicians, nurses, reimbursement specialists and patient care agents. Scope included specialty pharmacy operations and distribution, nursing clinical and site of care services, patient assistance foundation programs, field reimbursement and full… Show more Operational and Program Management leader responsible for large (>$1B annual revenues), multi-site national programs (AbbVie, Allergan, Amgen, AstraZeneca, Gilead, Johnson & Johnson, Pfizer, plus 65 others) supported by pharmacists, pharmacy technicians, nurses, reimbursement specialists and patient care agents. Scope included specialty pharmacy operations and distribution, nursing clinical and site of care services, patient assistance foundation programs, field reimbursement and full service hub solutions. Organization consisted of over 1200 clinical and non-clinical personnel across multiple locations. • Established metrics, redesigned process flows, and incorporated new leadership to stabilize relationship with billion dollar specialty Pharma client. Improved key performance indicators by as much as 70% thereby exceeding contractual goals in all key areas for first time in program history. • Launched over $100 million in new patient assistance and access programs. Increased staff by more than 500 personnel across multiple locations to support new business. • Saved in excess of $2 million in reallocation costs by instituting new staffing process during successful program closure. Show less
-
-
-
Positron Corporation
-
United States
-
Medical Equipment Manufacturing
-
1 - 100 Employee
-
Chief Operating Officer | COO
-
2012 - 2013
Defined and implemented strategies focused on accelerating growth across the company’s product portfolio. Additionally, led the Company’s sales and marketing initiatives focused on revenue generation, enhancing Positron’s industry position and brand recognition as a leader in nuclear medicine.
-
-
-
Intalere
-
United States
-
Hospitals and Health Care
-
100 - 200 Employee
-
Vice President, Marketing
-
2010 - 2012
Oversaw all aspects of the marketing organization including product development, innovation management, strategic planning, brand management, advertising & promotions, communications, public relations, and market research. • Oversaw the annual and five-year strategic business planning process. Evaluated new business opportunities through in-depth financial modeling. Process resulted in new market expansion with expected annual revenues of $400 million. • Determined market potential of… Show more Oversaw all aspects of the marketing organization including product development, innovation management, strategic planning, brand management, advertising & promotions, communications, public relations, and market research. • Oversaw the annual and five-year strategic business planning process. Evaluated new business opportunities through in-depth financial modeling. Process resulted in new market expansion with expected annual revenues of $400 million. • Determined market potential of over 100,000 key products through quantitative evaluation. Created a targeted marketing platform that leveraged this analysis to effectively prioritize the actions of the field sales force. Developed and led sales training on the new platform to over 200 field personnel. Featured product sales grew 450% faster than baseline. • Developed the brand positioning and marketing architecture including mission and vision statements, value proposition statements, master positioning statement, master internal and external messages, and segmented messaging. New platform was key in a one year sales and margin growth of 24% and 22%, respectively, in flat market conditions. • Developed key performance indicator matrix to measure and report on effectiveness of marketing campaigns. Increased marketing return on investment by 37% through data analysis, best practice implementation and resource reallocation. • Decreased average contact implementation time from 32 to 4 days by transitioning all sales collaterals and enrollment documents to a mobile platform. Increased implementation speed will result in an $80 million sales increase in 2013. • Created new social and mobile media platforms focused on driving Brand recognition and membership growth. Leveraged platforms to add 12,000 new members in two years. • Engaged and managed vendor partners to create and execute multiple advertising campaigns. Synergized print and digital formats to increase access while generating annual savings of $300,000. Show less
-
-
-
Mallinckrodt Pharmaceuticals
-
Ireland
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Senior Director, Business Development & Licensing, Imaging and Pharmaceuticals
-
2005 - 2010
Developed business cases focused on the identification of divestitures, acquisitions, alliances, strategic partnerships and collaborative marketing opportunities complementary to the corporation’s strategic plan. Led cross-functional teams in the development of recommendations on the prioritization of targets against the existing portfolio and market demands. Evaluated, negotiated and closed transactions for deals as large as $200 million. • Coordinated the divestiture of the Covidien’s… Show more Developed business cases focused on the identification of divestitures, acquisitions, alliances, strategic partnerships and collaborative marketing opportunities complementary to the corporation’s strategic plan. Led cross-functional teams in the development of recommendations on the prioritization of targets against the existing portfolio and market demands. Evaluated, negotiated and closed transactions for deals as large as $200 million. • Coordinated the divestiture of the Covidien’s 37-pharmacy distribution network with annual sales of over $160 million. • Championed new pricing strategy for key nuclear medicine product that resulted in $25 million in additional gross margin in first year of implementation. • Created alliance with international manufacturer for pharmacy automation. Implementation resulted in a system wide gross margin contribution of $7.6 million in the first year of implementation
-
-
Global Director of Product Marketing, Imaging Solutions
-
2004 - 2010
Developed comprehensive global strategic marketing plans for multiple critical care and medical device product lines with annual sales of over $1.1 billion. Oversaw new product launches at a global level.
-
-
Director of Product Marketing, US Nuclear Medicine
-
2004 - 2010
Directed marketing efforts for Nuclear Medicine product lines with annual sales in excess of $300 million. Developed effective marketing, pricing and channel strategies. Integrated market research, voice of customer assessments, and product benefits into effective marketing messages. Created advertising and promotional programs, developed tools for existing products and new product launches. Initiated metrics to report and measure success. * Generated a return of $10 million through… Show more Directed marketing efforts for Nuclear Medicine product lines with annual sales in excess of $300 million. Developed effective marketing, pricing and channel strategies. Integrated market research, voice of customer assessments, and product benefits into effective marketing messages. Created advertising and promotional programs, developed tools for existing products and new product launches. Initiated metrics to report and measure success. * Generated a return of $10 million through creation of four innovative sales incentive programs. Average program ROI exceeded 1,300% * Increased revenues $23 million through redesign of sales collaterals and messaging for five brand families.
-
-
Education
-
University of Michigan - Stephen M. Ross School of Business
MBA, Strategy and Operations -
Purdue University
BS Pharmacy, Pharmacy